Would you quit smoking if your employer promised you a sum $800 or Rs.50,000 over six months? The chances are very high, suggests a new study.
The researchers found that financial incentives, worth roughly $800 (Rs.50,860) over six months, helped more smokers kick the habit than providing free access to behavioral counseling and nicotine replacement therapy.
'Motivational Interviewing' can Help Smokers Quit Tobacco Consumption
It aims to produce changes in patient's behavior and make them see tobacco as something disagreeable, thus helping them to kick the habit.
Advertisement
"As we continue to see smoking as the number one cause of preventable death in the US, it is important for employers to consider different options to help their workers quit," said senior author Kevin Volpp from the University of Pennsylvania.
The findings are the result of a trial among CVS Caremark (now CVS Health) employees. The study enrolled 2,538 participants from across the US during an eight-month period in 2012.
![Indian Bidi Industry Risks the Health of Smokers and Bidi Workers too]( "Indian Bidi Industry Risks the Health of Smokers and Bidi Workers too")
Bidi smoking increases the risk of cancer, while continuous exposure to tobacco dust, many cause respiratory diseases, skin diseases and postural problems.
The employees were given different financial incentives, each worth roughly $800, and they could participate in the programs either individually or in groups.
Contrary to the researchers' expectations, the group-oriented programs were not significantly more successful than the individual-oriented programs -- 14 vs. 12%.
CVS Health said it would soon launch a campaign called "700 Good Reasons", whereby all employees who smoke would have to deposit just $50 (Rs.3,178), and if they tested negative for tobacco 12 months later, they would get back their $50 plus $700 (Rs.44,502) more, the company said.
The findings were published online in the New England Journal of Medicine.
Source: IANS
Indian Bidi Industry Risks the Health of Smokers and Bidi Workers too
Bidi smoking increases the risk of cancer, while continuous exposure to tobacco dust, many cause respiratory diseases, skin diseases and postural problems.
Advertisement
The employees were given different financial incentives, each worth roughly $800, and they could participate in the programs either individually or in groups.
Contrary to the researchers' expectations, the group-oriented programs were not significantly more successful than the individual-oriented programs -- 14 vs. 12%.
CVS Health said it would soon launch a campaign called "700 Good Reasons", whereby all employees who smoke would have to deposit just $50 (Rs.3,178), and if they tested negative for tobacco 12 months later, they would get back their $50 plus $700 (Rs.44,502) more, the company said.
The findings were published online in the New England Journal of Medicine.
Source: IANS
Plants Too Become Passive Smokers, Nicotine Presence Found in Spices, Herbal Teas
Passive smoking is bad for plants as they too absorb nicotine from cigarette smoke; other plants that grow in contaminated soil absorb it via roots.
Advertisement
 Weight Conscious Female Smokers Believe Smoking Helps Them Knock Off Extra KilosConcerns about weight are a significant barrier to quitting among smokers in the UK, and female smokers in the US believe smoking helps them manage weight. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
Consuming a diet rich in saturated fats triggers persistent, low-level inflammation within the body, ultimately contributing to the onset of metabolic syndrome.
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
